Search Results - Bernardez-Ferrán, B

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    CP-169 Influence of concomitant treatment with statins on survival outcomes of patients with metastatic castration resistant prostate cancer receiving abiraterone as firstline therapy

    CP-169 Influence of concomitant treatment with statins on survival outcomes of patients with metastatic castration resistant prostate cancer receiving abiraterone as firstline ther... by Lores, M Tourís, Paisán, E Espino, Montero, E López, López, C González-Anleo, Ferrán, B Bernárdez, Lamas, MJ

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    4CPS-075 Ibrutinib associated atrial fibrillation: incidence and management in the real life clinical setting

    4CPS-075 Ibrutinib associated atrial fibrillation: incidence and management in the real life clinical setting by Blanco-Dorado, S, Mosquera-Torre, A, López-Montero, E, Touris-Lores, M, Bernardez Ferran, B, Zarra-Ferro, I

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    5PSQ-115 Evaluation of hypothyroidism associated with apalutamide and enzalutamide treatment in metastatic prostate cancer using the European adverse effect database (EudraVigilance)

    5PSQ-115 Evaluation of hypothyroidism associated with apalutamide and enzalutamide treatment in metastatic prostate cancer using the European adverse effect database (EudraVigilanc... by Cajade, F, Touris Lores, M, Soto-Baselga, I, Bernardez-Ferrán, B, Santana-Martínez, S, Zarra-Ferro, I

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    4CPS-207 Evaluation of prostatic specific antigen depletion with abiraterone as a pronostative factor for survival in metastatic castration-sensitive prostate cancer

    4CPS-207 Evaluation of prostatic specific antigen depletion with abiraterone as a pronostative factor for survival in metastatic castration-sensitive prostate cancer by Cajade, F, Tourís-Lores, M, Pupla-Bartoll, A, Soto-Baselga, I, Bernárdez-Ferrán, B, Santana-Martínez, S, García-Quintanilla, L, Castro-Balado, A, Mosquera-Torre, A, López-Montero, E, Zarra-Ferro, I

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    4CPS-233 PD-l1 expression and histological type as predictors of response in metastasic non-small-cell lung cancer (NSCLC) patients treated with pembrolizumab in first-line

    4CPS-233 PD-l1 expression and histological type as predictors of response in metastasic non-small-cell lung cancer (NSCLC) patients treated with pembrolizumab in first-line by Touris-Lores, M, Busto-Iglesias, M, García-Quintanilla, L, Castro-Balado, A, Lopez-Montero, E, Mosquera-Torre, A, Bernardez-Ferran, B, Santana-Martinez, S, Vazquez-Troche, S, Mozo-Peñalver, HJ, Zarra-Ferro, I

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    4CPS-301 Association of antibiotics and proton pump inhibitors on clinical activity of firstline pembrolizumab for non-small cell lung cancer: 2 years of real world data

    4CPS-301 Association of antibiotics and proton pump inhibitors on clinical activity of firstline pembrolizumab for non-small cell lung cancer: 2 years of real world data by A Castro Balado, Lores, M Tourís, R Álvarez Sánchez, B Bernárdez Ferrán, E López Montero, A Mosquera Torre, B Mejuto Pérez Del Molino, Ferro, I Zarra

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    PS-086 Adding low dose allopurinol as hepatoprotector to the maintenance treatment with mercaptopurine in children with acute lymphoblastic leukaemia

    PS-086 Adding low dose allopurinol as hepatoprotector to the maintenance treatment with mercaptopurine in children with acute lymphoblastic leukaemia by Lopez-Montero, E, Mosquera-Torre, A, Touris-Lores, M, Sanchez-Iglesias, B, Bernardez-Ferran, B, Lamas-Diaz, MJ

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: